HiRO Partners with Monash Health to Speed Up Complex Clinical Trials
HiRO has formalized a new strategic partnership with Monash Health, one of Australia’s largest public health services, through a Site Alliance Agreement signed at BIO Asia-Taiwan in Taipei.
The agreement was signed on July 16 by Associate Professor Tam Nguyen, Director of Research and Innovation at Monash Health, and Cristina Chang, Global Chief Medical Officer at HiRO.
Why This Partnership Matters
One of the biggest challenges in clinical research is the gap between a finalized protocol and the first enrolled participant. Strategic site partnerships are one of the most effective ways to close that gap.
Monash Health operates a large hospital network across the greater Melbourne area, serving a broad and diverse patient population. For HiRO, this collaboration provides direct insight into patient pathways, access to specialized participant populations, and connection to established translational research infrastructure.
That combination matters most for complex and novel modalities, where feasible study design must be grounded in real clinical and operational reality from the start, not adjusted after the fact.
From Protocol to First Participant, Faster
Partnerships like this one are built to shorten the distance between protocol design and first participant enrolled. By working directly with a health system of Monash Health’s scale, HiRO can build study designs around what is truly feasible to execute on the ground, rather than designing in isolation and troubleshooting later.
Looking Ahead
This agreement reflects HiRO’s continued focus on building site relationships that support faster, more feasible study starts across complex therapeutic areas. It also underscores HiRO’s growing presence across the APAC region, where partnerships like this one help sponsors navigate local health systems with greater confidence.
As trial designs grow more complex, especially for novel modalities and specialized patient populations, this kind of on-the-ground insight becomes a differentiator rather than a nice-to-have.
Working with an established health system like Monash Health gives sponsors a clearer picture of what execution actually looks like before a study ever begins, which reduces risk and rework downstream. It’s the kind of collaboration HiRO plans to keep building on as it deepens its footprint across the region.
